000			02332 a2200673 4500
005			20250513190520.0
264		0	_c19990816
008			199908s 0 0 eng d
022			_a0003-3197
024	7		_a10.1177/000331979905000707 _2doi
040			_aNLM _beng _cNLM
100	1		_aShibata, M
245	0	0	_aEffect of magnesium sulfate pretreatment and significance of matrix metalloproteinase-1 and interleukin-6 levels in coronary reperfusion therapy for patients with acute myocardial infarction. _h[electronic resource]
260			_bAngiology _cJul 1999
300			_a573-82 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAngina Pectoris _xetiology
650	0	4	_aAngioplasty, Balloon, Coronary
650	0	4	_aArrhythmias, Cardiac _xetiology
650	0	4	_aCalcium _xmetabolism
650	0	4	_aCalcium Channel Blockers _xadministration & dosage
650	0	4	_aCollagenases _xblood
650	0	4	_aComplement System Proteins _xdrug effects
650	0	4	_aElectrocardiography _xdrug effects
650	0	4	_aFemale
650	0	4	_aFibrinolytic Agents _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aInjections, Intravenous
650	0	4	_aInterleukin-6 _xblood
650	0	4	_aMagnesium _xblood
650	0	4	_aMagnesium Sulfate _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMatrix Metalloproteinase 1
650	0	4	_aMiddle Aged
650	0	4	_aMuscle, Smooth, Vascular _xdrug effects
650	0	4	_aMyocardial Infarction _xdrug therapy
650	0	4	_aMyocardial Reperfusion Injury _xetiology
650	0	4	_aMyocardium _xmetabolism
650	0	4	_aPlacebos
650	0	4	_aPremedication
650	0	4	_aRecurrence
650	0	4	_aThrombolytic Therapy
650	0	4	_aTissue Plasminogen Activator _xtherapeutic use
700	1		_aUeshima, K
700	1		_aHarada, M
700	1		_aNakamura, M
700	1		_aHiramori, K
700	1		_aEndo, S
700	1		_aSato, N
700	1		_aMukaida, H
700	1		_aSuzuki, T
700	1		_aSuzuki, T
700	1		_aInada, K
773	0		_tAngiology _gvol. 50 _gno. 7 _gp. 573-82
856	4	0	_uhttps://doi.org/10.1177/000331979905000707 _zAvailable from publisher's website
999			_c10389786 _d10389786